Moderna Inc (MRNA)

$53.31 +0.75 (1.43%)
Market Cap 20.76B
Revenue (ttm) 1.94B
Net Income (ttm) -2.82B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -145.16%
Debt to Equity Ratio 0.07
Volume 6,969,000
Avg Vol 12,150,572
Day's Range N/A - N/A
Shares Out 394.94M
Stochastic %K 40%
Beta 1.29
Analysts Hold
Price Target $41.80

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
ShadowBanningIsBad
ShadowBanningIsBad Mar. 17 at 3:27 AM
$XBI $PFE $MRNA $GSK $MRK we were always taught decisions were made by represnatives. Some people know by preschool that judges and un elected twats run things. Where I reside no one takes vaccines. Few people have any disease or ever see a doctor from 10 to 60. Americans should be vaccinated.
0 · Reply
RonIsWrong
RonIsWrong Mar. 17 at 12:51 AM
$XBI Judge Strikes Down Kennedy’s Vaccine Policies cc $PFE $MRNA $GSK $MRK Ruling on a lawsuit brought by several prominent medical organizations, a district court said the federal government had not based its decisions on science in limiting Covid shots and revising the childhood immunization schedule.
2 · Reply
IndyOne
IndyOne Mar. 16 at 10:47 PM
$MRNA MAJOR WIN 🏆 https://archive.is/20260316205534/https://www.washingtonpost.com/health/2026/03/16/rfk-vaccine-policy-blocked-lawsuit/
0 · Reply
Betterworld1
Betterworld1 Mar. 16 at 10:16 PM
$MRNA Judge Strikes Down Kennedy’s Vaccine Policies Ruling on a lawsuit brought by several prominent medical organizations, a district court said the federal government had not based its decisions on science in limiting Covid shots and revising the childhood immunization schedule.
1 · Reply
DallasNV
DallasNV Mar. 16 at 9:53 PM
$NVAX $MRNA Moderna vs Novavax (2025) Cash: $8.1B vs $0.75B Revenue: $1.9B vs $1.1B Costs/year: $7–8B vs $0.4B Costs/day: $20M vs $1M Products or possible products: COVID, Flu, COVID+Flu combo, RSV, Cancer It is interesting that both companies are targeting almost the same products. Of course, this comparison is extremely simplified and not entirely accurate, because many other factors are not included here. But if you were to look strictly at this table, Novavax could theoretically overtake Moderna financially within about 2 years.
3 · Reply
DragonAlgo
DragonAlgo Mar. 16 at 9:44 PM
🐉 $MRNA CALL — DragonAlgo® Signal Contract: MRNA CALL Expiry: 2026-03-20 | Strike: $53.00 | Type: CALL Option Plan (premium): Entry: $2.01 Stop: $1.45 TP1: $2.61 TP2: $3.42 TP3: $4.82 🔗 https://dragonalgo.com
0 · Reply
taxplanr
taxplanr Mar. 16 at 9:40 PM
Will the road block that has kept the Trump admin from pulling the mRNA bioweapon off the market gotten the message? $BNTX $MRNA $PFE $MRK $BMY
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Mar. 16 at 9:18 PM
$MRNA is it time to short or keep waiting?
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Mar. 16 at 9:17 PM
$MRNA $SPY up 13% very interesting. Where do you think $MRNA will be in a month?
0 · Reply
IndyOne
IndyOne Mar. 16 at 8:03 PM
$MRNA Buying by institutions, nice close. 1.38 million shares on the close. Massive.
0 · Reply
Latest News on MRNA
Moderna, Inc. (MRNA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 10, 2026, 11:40 AM EDT - 6 days ago

Moderna, Inc. (MRNA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Mar 9, 2026, 1:32 PM EDT - 7 days ago

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

CAPR

FDA reversals leave investors worrying about the fates of other experimental drugs

Mar 6, 2026, 11:33 AM EST - 10 days ago

FDA reversals leave investors worrying about the fates of other experimental drugs

DNLI RGNX WVE

The Sun Will Shine On Moderna Again - Initiating With A Buy

Mar 4, 2026, 3:16 PM EST - 12 days ago

The Sun Will Shine On Moderna Again - Initiating With A Buy

Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom

Mar 4, 2026, 11:05 AM EST - 12 days ago

Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Mar 4, 2026, 8:26 AM EST - 12 days ago

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Mar 4, 2026, 8:14 AM EST - 12 days ago

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Mar 4, 2026, 5:25 AM EST - 12 days ago

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Mar 3, 2026, 5:30 PM EST - 13 days ago

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

Mar 3, 2026, 4:46 PM EST - 13 days ago

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

ABUS

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

Mar 3, 2026, 4:26 PM EST - 13 days ago

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

ABUS ROIV

Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 3, 2026, 4:22 PM EST - 13 days ago

Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna

Mar 3, 2026, 4:15 PM EST - 13 days ago

Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna

ABUS ROIV

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Mar 3, 2026, 4:15 PM EST - 13 days ago

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

ABUS ROIV

Moderna Resolves Global Patent Litigation with Arbutus/Genevant

Mar 3, 2026, 4:15 PM EST - 13 days ago

Moderna Resolves Global Patent Litigation with Arbutus/Genevant

ABUS

Moderna's Covid-Flu Vaccine Recommended for Approval in EU

Feb 27, 2026, 7:23 AM EST - 17 days ago

Moderna's Covid-Flu Vaccine Recommended for Approval in EU

European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Feb 27, 2026, 7:00 AM EST - 17 days ago

European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Moderna gets EU regulator nod for combined COVID, flu vaccine

Feb 27, 2026, 6:09 AM EST - 17 days ago

Moderna gets EU regulator nod for combined COVID, flu vaccine

Moderna Stock: How Far Can The Flu Shot Fly?

Feb 24, 2026, 10:40 AM EST - 20 days ago

Moderna Stock: How Far Can The Flu Shot Fly?

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 21 days ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK PFE

BioNTech sues Moderna for patent infringement over COVID-19 shots

Feb 19, 2026, 1:25 PM EST - 25 days ago

BioNTech sues Moderna for patent infringement over COVID-19 shots

BNTX

Moderna to Present at Upcoming Conferences in March 2026

Feb 19, 2026, 7:00 AM EST - 25 days ago

Moderna to Present at Upcoming Conferences in March 2026

FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars

Feb 18, 2026, 1:20 PM EST - 26 days ago

FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

Feb 18, 2026, 11:17 AM EST - 26 days ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

Moderna Shares Rally 6% After FDA Reverses Decision Not To Review Flu Vaccine

Feb 18, 2026, 11:00 AM EST - 26 days ago

Moderna Shares Rally 6% After FDA Reverses Decision Not To Review Flu Vaccine

Moderna got the FDA to change its mind and review its flu vaccine after some concessions

Feb 18, 2026, 10:22 AM EST - 26 days ago

Moderna got the FDA to change its mind and review its flu vaccine after some concessions

FDA reverses decision not to review Moderna's new flu vaccine

Feb 18, 2026, 9:35 AM EST - 26 days ago

FDA reverses decision not to review Moderna's new flu vaccine

Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising.

Feb 18, 2026, 9:27 AM EST - 26 days ago

Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising.

The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot

Feb 18, 2026, 9:12 AM EST - 26 days ago

The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

Feb 18, 2026, 7:13 AM EST - 26 days ago

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

US FDA to initiate review of Moderna's influenza vaccine

Feb 18, 2026, 7:07 AM EST - 26 days ago

US FDA to initiate review of Moderna's influenza vaccine

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Feb 18, 2026, 7:00 AM EST - 26 days ago

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

Feb 17, 2026, 7:00 AM EST - 27 days ago

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

Moderna, Inc. (MRNA) Price Forecast: Breakout Signals New Bull Trend

Feb 13, 2026, 4:53 PM EST - 4 weeks ago

Moderna, Inc. (MRNA) Price Forecast: Breakout Signals New Bull Trend

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

Feb 13, 2026, 4:13 PM EST - 4 weeks ago

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript

Feb 13, 2026, 12:47 PM EST - 4 weeks ago

Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript

Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms

Feb 13, 2026, 10:59 AM EST - 4 weeks ago

Moderna Promises Revenue Growth In 2026, Even As FDA Flu Vaccine Setback Looms

Moderna Narrows Loss, Reiterates 10% Revenue Growth Target

Feb 13, 2026, 7:56 AM EST - 4 weeks ago

Moderna Narrows Loss, Reiterates 10% Revenue Growth Target

Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings.

Feb 13, 2026, 7:13 AM EST - 4 weeks ago

Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings.

Moderna beats fourth-quarter revenue estimates

Feb 13, 2026, 7:06 AM EST - 4 weeks ago

Moderna beats fourth-quarter revenue estimates

Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Feb 13, 2026, 7:00 AM EST - 4 weeks ago

Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Moderna Stock Sports Technical Support Ahead Of Earnings

Feb 12, 2026, 3:25 PM EST - 4 weeks ago

Moderna Stock Sports Technical Support Ahead Of Earnings

Why is the FDA refusing Moderna's application for a new mRNA flu vaccine?

Feb 12, 2026, 5:10 AM EST - 4 weeks ago

Why is the FDA refusing Moderna's application for a new mRNA flu vaccine?

The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division

Feb 11, 2026, 9:00 PM EST - 4 weeks ago

The FDA's refusal to review Moderna's application to sell a new flu shot is part of a pattern of regulatory U-turns and overruling of FDA staff by Vinay Prasad, head of the agency's vaccine division

FDA blindsides Moderna with refusal to review flu vaccine application: ‘We're pretty confused'

Feb 11, 2026, 3:15 PM EST - 4 weeks ago

FDA blindsides Moderna with refusal to review flu vaccine application: ‘We're pretty confused'

The FDA Refuses To Review Moderna's Flu Vaccine

Feb 11, 2026, 12:17 PM EST - 4 weeks ago

The FDA Refuses To Review Moderna's Flu Vaccine

Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says

Feb 11, 2026, 10:44 AM EST - 4 weeks ago

Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says

Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine.

Feb 11, 2026, 7:05 AM EST - 4 weeks ago

Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine.

Wall Street Breakfast Podcast: Amazon Adds BETA To Cart

Feb 11, 2026, 6:24 AM EST - 4 weeks ago

Wall Street Breakfast Podcast: Amazon Adds BETA To Cart

AMZN BETA EL WMT

ShadowBanningIsBad
ShadowBanningIsBad Mar. 17 at 3:27 AM
$XBI $PFE $MRNA $GSK $MRK we were always taught decisions were made by represnatives. Some people know by preschool that judges and un elected twats run things. Where I reside no one takes vaccines. Few people have any disease or ever see a doctor from 10 to 60. Americans should be vaccinated.
0 · Reply
RonIsWrong
RonIsWrong Mar. 17 at 12:51 AM
$XBI Judge Strikes Down Kennedy’s Vaccine Policies cc $PFE $MRNA $GSK $MRK Ruling on a lawsuit brought by several prominent medical organizations, a district court said the federal government had not based its decisions on science in limiting Covid shots and revising the childhood immunization schedule.
2 · Reply
IndyOne
IndyOne Mar. 16 at 10:47 PM
$MRNA MAJOR WIN 🏆 https://archive.is/20260316205534/https://www.washingtonpost.com/health/2026/03/16/rfk-vaccine-policy-blocked-lawsuit/
0 · Reply
Betterworld1
Betterworld1 Mar. 16 at 10:16 PM
$MRNA Judge Strikes Down Kennedy’s Vaccine Policies Ruling on a lawsuit brought by several prominent medical organizations, a district court said the federal government had not based its decisions on science in limiting Covid shots and revising the childhood immunization schedule.
1 · Reply
DallasNV
DallasNV Mar. 16 at 9:53 PM
$NVAX $MRNA Moderna vs Novavax (2025) Cash: $8.1B vs $0.75B Revenue: $1.9B vs $1.1B Costs/year: $7–8B vs $0.4B Costs/day: $20M vs $1M Products or possible products: COVID, Flu, COVID+Flu combo, RSV, Cancer It is interesting that both companies are targeting almost the same products. Of course, this comparison is extremely simplified and not entirely accurate, because many other factors are not included here. But if you were to look strictly at this table, Novavax could theoretically overtake Moderna financially within about 2 years.
3 · Reply
DragonAlgo
DragonAlgo Mar. 16 at 9:44 PM
🐉 $MRNA CALL — DragonAlgo® Signal Contract: MRNA CALL Expiry: 2026-03-20 | Strike: $53.00 | Type: CALL Option Plan (premium): Entry: $2.01 Stop: $1.45 TP1: $2.61 TP2: $3.42 TP3: $4.82 🔗 https://dragonalgo.com
0 · Reply
taxplanr
taxplanr Mar. 16 at 9:40 PM
Will the road block that has kept the Trump admin from pulling the mRNA bioweapon off the market gotten the message? $BNTX $MRNA $PFE $MRK $BMY
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Mar. 16 at 9:18 PM
$MRNA is it time to short or keep waiting?
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Mar. 16 at 9:17 PM
$MRNA $SPY up 13% very interesting. Where do you think $MRNA will be in a month?
0 · Reply
IndyOne
IndyOne Mar. 16 at 8:03 PM
$MRNA Buying by institutions, nice close. 1.38 million shares on the close. Massive.
0 · Reply
IndyOne
IndyOne Mar. 16 at 7:58 PM
$MRNA We've got cowbell !!!
0 · Reply
IndyOne
IndyOne Mar. 16 at 7:51 PM
$MRNA Strong green candles
1 · Reply
IndyOne
IndyOne Mar. 16 at 7:27 PM
$MRNA Rumor of discussions with a major Pharma. So many bread crumbs.
1 · Reply
KingZack25
KingZack25 Mar. 16 at 6:57 PM
$MRNA big volume. Something coming today AH?
1 · Reply
IndyOne
IndyOne Mar. 16 at 6:26 PM
$MRNA I ❤️ MODERNA !!! Vinay Prasad, the former head of the FDA’s Center for Biologics Evaluation and Research (CBER)
0 · Reply
IndyOne
IndyOne Mar. 16 at 3:43 PM
$MRNA When Phase 3 (V940) succeeds for Moderna’s melanoma vaccine, it will become the first approved personalized mRNA cancer vaccine in history. It is also being tested for lung cancer and more. Massive franchise being built. Merck has bought in and V940 will extend Keytruda patent that is ending soon. https://www.theglobeandmail.com/investing/markets/stocks/MRNA/pressreleases/347281/moderna-and-merck-advance-mrna-cancer-vaccine-trial-in-first-line-lung-cancer-what-investors-should-watch/
0 · Reply
IndyOne
IndyOne Mar. 16 at 3:11 PM
$MRNA No more roadblocks from FDA and Europe is recommending approval of COMBO. FDA will now approve after Vinay Prasad termination. Look for FDA approval of COMBO soon. https://www.reuters.com/business/healthcare-pharmaceuticals/us-vaccine-advisers-drop-plan-question-mrna-covid-shots-wapo-reports-2026-03-11/
0 · Reply
Jdoe12345
Jdoe12345 Mar. 16 at 2:27 PM
$MRNA https://www.nytimes.com/2026/03/15/health/covid-vaccine-side-effects-cdc-acip.html?smid=nytcore-ios-share
0 · Reply
taxplanr
taxplanr Mar. 16 at 2:23 PM
Ivermectin Fenbendazole and Mebendazole curing Pancreatic Cancer $BNTX $MRNA $BMY $MRK https://makisw.substack.com/p/ivermectin-fenbendazole-and-mebendazole-a39?utm_source=post-email-title&publication_id=1385328&post_id=191125750&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
IndyOne
IndyOne Mar. 16 at 1:24 AM
$MRNA More cowbell.
0 · Reply
KingZack25
KingZack25 Mar. 16 at 1:01 AM
$SPY $MRNA $SMCI $TTD $HPQ Moderna Short squeeze inbound
0 · Reply